{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T01:39:20Z","timestamp":1775871560652,"version":"3.50.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2016,12,17]],"date-time":"2016-12-17T00:00:00Z","timestamp":1481932800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1007\/s00432-016-2314-1","type":"journal-article","created":{"date-parts":[[2016,12,17]],"date-time":"2016-12-17T11:49:41Z","timestamp":1481975381000},"page":"693-701","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Fingerprint changes among cancer patients treated with paclitaxel"],"prefix":"10.1007","volume":"143","author":[{"given":"Payam","family":"Azadeh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simin","family":"Dashti-Khavidaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali Yaghobi","family":"Joybari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samaneh","family":"Sarbaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atefeh","family":"Jafari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehdi","family":"Yaseri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Afshin","family":"Amini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryam","family":"Farasatinasab","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,12,17]]},"reference":[{"issue":"2","key":"2314_CR1","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1634\/theoncologist.2011-0243","volume":"17","author":"MS Al-Ahwal","year":"2012","unstructured":"Al-Ahwal MS (2012) Chemotherapy and fingerprint loss: beyond cosmetic. Oncologist 17(2):291\u2013293. doi: 10.1634\/theoncologist.2011-0243","journal-title":"Oncologist"},{"issue":"3","key":"2314_CR2","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1159\/000352097","volume":"8","author":"HA Assi","year":"2013","unstructured":"Assi HA, Ayoub ZA, Jaber SM, Sibai HA, El Saghir NS (2013) Management of paclitaxel-induced hand-foot syndrome. Breast Care (Basel) 8(3):215\u2013217. doi: 10.1159\/000352097","journal-title":"Breast Care (Basel)"},{"issue":"9","key":"2314_CR3","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1177\/1060028014539145","volume":"48","author":"P Azadeh","year":"2014","unstructured":"Azadeh P, Yaghobi Joybari A, Amini A, Farasatinasab M (2014) Paclitaxel-Induced Fingerprints Loss. Ann Pharmacother 48(9):1249\u20131250. doi: 10.1177\/1060028014539145","journal-title":"Ann Pharmacother"},{"key":"2314_CR4","doi-asserted-by":"crossref","DOI":"10.5005\/jp\/books\/11334","volume-title":"Principles of forensic medicine and toxicology","author":"R Bardale","year":"2011","unstructured":"Bardale R (2011) Principles of forensic medicine and toxicology. Jaypee Brothers Medical Publishers (P) Ltd, New Delhi"},{"issue":"2","key":"2314_CR5","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1200\/JCO.1999.17.2.485","volume":"17","author":"JL Blum","year":"1999","unstructured":"Blum JL, Jones SE, Buzder AU, LoRusso PM, Kuter I, Vogel C, Osterwalder B et al (1999) Multicenter phase II study of capecitabine in paclitaxel refractory metastatic breast cancer. J Clin Oncol 17(2):485","journal-title":"J Clin Oncol"},{"issue":"4","key":"2314_CR6","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.scijus.2015.02.004","volume":"55","author":"S Cadd","year":"2015","unstructured":"Cadd S, Islam M, Manson P, Bleay S (2015) Fingerprint composition and aging: a literature review. Sci Justice 55(4):219\u2013223","journal-title":"Sci Justice"},{"issue":"16","key":"2314_CR7","doi-asserted-by":"publisher","first-page":"e22","DOI":"10.1056\/NEJMicm1409635","volume":"327","author":"Y Chavarri-Guerra","year":"2015","unstructured":"Chavarri-Guerra Y, Soto-Perez-de-Celis E (2015) Loss of fingerprints. N Engl J Med 327(16):e22. doi: 10.1056\/NEJMicm1409635","journal-title":"N Engl J Med"},{"key":"2314_CR8","isbn-type":"print","volume-title":"Implementing biometric security","author":"J Chirillo","year":"2003","unstructured":"Chirillo J, Blsul S (2003) Implementing biometric security. Wiley, Hoboken. ISBN 978-0-7645-2502-6","ISBN":"https:\/\/id.crossref.org\/isbn\/9780764525026"},{"key":"2314_CR9","unstructured":"Common terminology criteria for adverse events, version 4.03, June 2010, National Institutes of Health, National Cancer Institute, file:http\/\/ www.evs.nci.nih.gov\/ftp1\/CTCAE\/CTCAE_4.03_2010-06-14_QuickReference_5x7.pdf"},{"key":"2314_CR10","doi-asserted-by":"crossref","first-page":"86","DOI":"10.2340\/00015555-0956","volume":"91","author":"A Cruz","year":"2011","unstructured":"Cruz A, Temu T, Hines-Telang G, Kroumpouzos G (2011) Paclitaxel-induced neutrophilic adverse reaction and acral erythema. Acta Derm Venereol 91:86\u201387","journal-title":"Acta Derm Venereol"},{"key":"2314_CR11","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1159\/000246419","volume":"192","author":"D Arila De","year":"1996","unstructured":"De Arila D, Dominguez JD, Iglesias L (1996) Taxol-induced acral erythema. Dermatology 192:377\u2013378","journal-title":"Dermatology"},{"key":"2314_CR12","doi-asserted-by":"crossref","first-page":"626148","DOI":"10.1155\/2012\/626148","volume":"2012","author":"M Drahansky","year":"2012","unstructured":"Drahansky M, Dolezel M, Urbanek J, Brezinova E, Kim TH (2012) Influence of skin diseases on fingerprint recognition. J Biomed Biotechnol 2012:626148","journal-title":"J Biomed Biotechnol"},{"issue":"5","key":"2314_CR13","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1345\/aph.18307","volume":"33","author":"SM Flory","year":"1999","unstructured":"Flory SM, Solimando DA Jr, Webster GF, Dunton CJ, Neufeld JM, Haffey MB (1999) Onycholysis associated with weekly administration of paclitaxel. Ann Pharmacother 33(5):584\u2013586","journal-title":"Ann Pharmacother"},{"issue":"13","key":"2314_CR14","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1200\/JCO.2007.11.3100","volume":"25","author":"JA Garcia-Saenz","year":"2007","unstructured":"Garcia-Saenz JA, Martin M, Diaz-Rubio E (2007) Elementary, my dear Watson. J Clin Oncol 25(13):1815\u20131816","journal-title":"J Clin Oncol"},{"issue":"1","key":"2314_CR15","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.forsciint.2012.05.018","volume":"223","author":"A Girod","year":"2012","unstructured":"Girod A, Ramotowski R, Weyermann C (2012) Composition of fingermark residue: a qualitative and quantitative review. Forensic Sci Int 223(1):10\u201324","journal-title":"Forensic Sci Int"},{"key":"2314_CR50","doi-asserted-by":"crossref","unstructured":"Hirji KF (2005) Exact analysis of discrete data. Chapman and Hall\/CRC Press, Boca Raton, FL","DOI":"10.1201\/9781420036190"},{"issue":"1","key":"2314_CR16","first-page":"21","volume":"3","author":"R Haber","year":"2015","unstructured":"Haber R, Helou J, Korkomaz J, Habre M, Ghanem A, Tomb R (2015) Absence of fingertips with focus on dermatological etiologies: national survey and review. Clin Dermatol 3(1):21\u201326","journal-title":"Clin Dermatol"},{"key":"2314_CR17","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0001-7310(08)74677-5","volume":"99","author":"L Hueso","year":"2008","unstructured":"Hueso L, Sanmart\u00edn O, Nagore E, Botella- Estrada R, Requena C, Llombart B, Serra- Guill\u00e9n C, Alfaro-Rubio A, Guill\u00e9n C (2008) Chemotherapy-induced acral erythema: a clinical and histopathologic study of 44 cases. Actas Dermosifiliogr 99:281\u2013290","journal-title":"Actas Dermosifiliogr"},{"key":"2314_CR18","isbn-type":"print","doi-asserted-by":"crossref","DOI":"10.1007\/978-0-387-71041-9","volume-title":"Handbook of biometrics","author":"AK Jain","year":"2008","unstructured":"Jain AK, Flynn P, Ross AA (2008) Handbook of biometrics. Springer, Berlin. ISBN 978-0-387-71040-2","ISBN":"https:\/\/id.crossref.org\/isbn\/9780387710402"},{"key":"2314_CR19","volume-title":"Drug information handbook","year":"2011","unstructured":"Lacy CF, Armstrong LL, Goldman MP, Lance LL (eds) (2011) Drug information handbook, 20th edn. Lexi-Comp, Hudson","edition":"20"},{"issue":"Suppl 1","key":"2314_CR20","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1016\/j.ejon.2004.06.007","volume":"8","author":"Y Lassere","year":"2004","unstructured":"Lassere Y, Hoff P (2004) Management of hand-foot syndrome in patients treated with capecitabine (Xeloda). Eur J Oncol Nurs 8(Suppl 1):S31\u2013S40","journal-title":"Eur J Oncol Nurs"},{"issue":"9","key":"2314_CR21","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1200\/JCO.1998.16.9.2977","volume":"16","author":"M Mackean","year":"1998","unstructured":"Mackean M, Planting A, Twelves C, Schellens J, Allman D, Osterwalder B et al (1998) Phase I and pharmacologic study of intermittent twice-daily oral therapy with capecitabine in patients with advanced and\/or metastatic cancer. J Clin Oncol 16(9):2977\u20132985","journal-title":"J Clin Oncol"},{"key":"2314_CR22","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1097\/00007611-199605000-00022","volume":"89","author":"JY Payne","year":"1996","unstructured":"Payne JY, Holmes F, Cohen PR, Gagel R, Buzdar A, Dhingra K (1996) Paclitaxel: severe mucocutaneous toxicity in a patient with hyperbilirubinemia. South Med J 89:542\u2013545","journal-title":"South Med J"},{"key":"2314_CR51","unstructured":"R Core Team (2014) R: a language and environment for statistical computing. R foundation for statistical computing, Vienna, Austria. http:\/\/www.R-project.org\/"},{"issue":"1","key":"2314_CR23","doi-asserted-by":"crossref","first-page":"124","DOI":"10.3349\/ymj.2007.48.1.124","volume":"48","author":"MR Roh","year":"2007","unstructured":"Roh MR, Cho JY, Lew W (2007) Docetaxel-induced onycholysis: the role of subungual hemorrhage and suppuration. Yonsei Med J 48(1):124\u2013126","journal-title":"Yonsei Med J"},{"issue":"6","key":"2314_CR24","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1111\/j.1365-2230.2011.04307.x","volume":"37","author":"A Sergeant","year":"2012","unstructured":"Sergeant A, McPhee N, Holme SA (2012) Acquired loss of fingerprints: do topical corticosteroids play an aetiological role? Clin Exp Dermatol 37(6):679\u2013680. doi: 10.1111\/j.1365-2230.2011.04307.x","journal-title":"Clin Exp Dermatol"},{"issue":"7","key":"2314_CR25","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1093\/annonc\/mdp278","volume":"20","author":"M Wong","year":"2009","unstructured":"Wong M, Choo SP, Tan EH (2009) Travel warning with capecitabine. Ann Oncol 20(7):1281. doi: 10.1093\/annonc\/mdp278","journal-title":"Ann Oncol"},{"key":"2314_CR26","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1111\/j.1365-2133.2007.08357.x","volume":"158","author":"CH Yang","year":"2008","unstructured":"Yang CH, Lin WC, Chuang CK, Chang YC, Pang ST, Lin YC et al (2008) Hand-foot skin reaction in patients treated with sorafenib: a clinicopathological study of cutaneous manifestations due to multitargeted kinase inhibitor therapy. Br J Dermatol 158:592\u2013596","journal-title":"Br J Dermatol"},{"key":"2314_CR27","volume-title":"Cancer symptom management","year":"2004","unstructured":"Yarbro CH, Frogge MH, Goodman M (eds) (2004) Cancer symptom management, 3rd edn. Jones and Bartlett Publishers, Sudbury","edition":"3"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-016-2314-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00432-016-2314-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-016-2314-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,25]],"date-time":"2017-06-25T02:08:27Z","timestamp":1498356507000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00432-016-2314-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12,17]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["2314"],"URL":"https:\/\/doi.org\/10.1007\/s00432-016-2314-1","relation":{},"ISSN":["0171-5216","1432-1335"],"issn-type":[{"value":"0171-5216","type":"print"},{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12,17]]}}}